APA (7th ed.) Citation

Kevin V. Kwee, Jean-Luc Murk, Qiqi Yin, M. Birgitte Visch, Linda Davidson, Elke M. G. J. de Jong, . . . Milan Tjioe. (2023). Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: A cross-sectional cohort study (PsoCOVID). Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Kevin V. Kwee, Jean-Luc Murk, Qiqi Yin, M. Birgitte Visch, Linda Davidson, Elke M. G. J. de Jong, Juul M. P. A. van den Reek, and Milan Tjioe. Prevalence, Risk and Severity of SARS-CoV-2 Infections in Psoriasis Patients Receiving Conventional Systemic, Biologic or Topical Treatment During the COVID-19 Pandemic: A Cross-sectional Cohort Study (PsoCOVID). Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Kevin V. Kwee, et al. Prevalence, Risk and Severity of SARS-CoV-2 Infections in Psoriasis Patients Receiving Conventional Systemic, Biologic or Topical Treatment During the COVID-19 Pandemic: A Cross-sectional Cohort Study (PsoCOVID). Taylor & Francis Group, 2023.